Data Foundry

Drug recalls 2023

PHENYLephrine in 0 — Class II drug recall D-1077-2023

Terminated recall by Central Admixture Pharmacy Services Inc, reported 2023-08-09, distributed nationwide. Lack of assurance of sterility: Lack of validation data for sanitization cycles

Recall numberD-1077-2023
Product typeDrug
ClassificationClass II
StatusTerminated
Voluntary or mandatedVoluntary
Recalling firmCentral Admixture Pharmacy Services Inc, San Diego, CA, United States
Recall initiated2023-07-17
Classified2023-08-03
Reported by FDA2023-08-09
Terminated2025-03-21
DistributedNationwide (US)
Quantity10,494 syringes
Reason classessterility
NDC71286-6008-01
Lot numbers17-270678, 17-270695, 17-270880, 17-271075, 17-271233, 17-271269, 17-271492, 17-271494, 17-271748, 17-271891, 17-271945, 17-272221, 17-272236, 17-272286, 17-272305, 17-272642, 17-272997, 17-272998, 17-273478, 17-273496, 17-273497, 17-274139, 17-274156, 17-274163
Expiration dates2023-07-18, 2023-07-20, 2023-07-24, 2023-07-26, 2023-07-31, 2023-08-03, 2023-08-07, 2023-08-08, 2023-08-13, 2023-08-14, 2023-08-20, 2023-08-24, 2023-09-04, 2023-09-13

Product

PHENYLephrine in 0.9 sodium chloride, 800 mcg /10 mL, (80 mcg/mL), 10 mL Syringe, Rx only, CAPS, Inc., 7935 Dunbrook Road, Suite C, San Diego, CA 92126, NDC 71286-6008-1

Reason for recall

Lack of assurance of sterility: Lack of validation data for sanitization cycles

Machine access

This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-1077-2023. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.

Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.